Cancer Genetics and Epigenetics, 2025, Vol.13, No.5, 224-235 http://medscipublisher.com/index.php/cge 232 Data security is as crucial as privacy. Digital health platforms collect a large amount of sensitive health information, which must be prevented from being viewed or misused by unauthorized parties. Implementing strict data protection measures, formulating transparent privacy policies and complying with regulatory requirements are important foundations for maintaining patient trust and promoting the wide application of these technologies (Ancona et al., 2025). Solving the above problems is of great significance for giving full play to the value of digital health intervention in cancer treatment and benefiting more patients. 8.2 Future directions With the support of artificial intelligence (AI) and big data, future digital health for tumors will develop towards more personalized and flexible interventions. Artificial intelligence models can provide personalized suggestions by analyzing a large amount of information such as patient feedback, wearable device data, and electronic medical records, predict the risk of possible symptom deterioration, and optimize care plans for different patients. These methods can help enhance the ability to make real-time decisions, improve symptom management, and also enable measures to be taken in advance based on the actual situation and changes in the patient's condition. As digital health platforms become increasingly sophisticated, personalized functions centered on artificial intelligence will become an important way to enhance clinical outcomes and encourage more patients to actively participate in anti-cancer treatment. 8.3 Strategy and system support To promote digital health intervention, it is necessary to establish a more complete policy and support system, such as including digital tools and remote monitoring in the medical insurance reimbursement scope (Pierce et al., 2024). Integrating digital health solutions into clinical guidelines and diagnosis and treatment processes can promote standardized use and ensure consistent service quality across different hospitals. It is crucial for doctors, IT professionals, policymakers and patient representatives to work together to develop user-friendly, scientifically reliable and practical platforms. This system-level support can promote the continuous use of digital health intervention measures, thereby improving the quality of life and treatment outcomes of cancer patients. 9 Concluding Remarks Digital health interventions achieved through mobile applications and remote monitoring have generally had a positive impact on the quality of life (QoL) of cancer patients. Multiple pooled studies and systematic evaluations have shown that compared with conventional care, such interventions can significantly improve patients' overall quality of life and self-management ability, and help alleviate anxiety, depression and physical discomfort. Most intervention measures are highly feasible, have good acceptance among patients, and have a strong willingness to participate. They can integrate well into auxiliary care, especially during active treatment and postoperative rehabilitation. Although the current results are encouraging, the evidence still has some limitations at present, such as inconsistent intervention regimens, short follow-up periods, and the lack of large-sample, rigorously designed randomized controlled trials that can evaluate long-term effects. Many studies only focus on certain types of cancer or short-term effects, so the conclusions are difficult to generalize to all groups, and the long-term benefits and potential risks also need further verification. To better leverage the role of digital health intervention in tumor treatment, in the future, emphasis should be placed on clinical implementation, continuous improvement of technology, and efforts should be made to secure policy support, such as incorporating relevant practices into medical insurance reimbursement and clinical guidelines. Doctors, technicians and policymakers need to enhance collaboration so that these tools can be more user-friendly, safer, accessible to all and fairer, ultimately improving the quality of life for all cancer patients. Acknowledgments The authors extend sincere thanks to Dr. Zhang for their feedback on the manuscript.
RkJQdWJsaXNoZXIy MjQ4ODYzNA==